Abbott, a leader in diabetes tech with one of the biggest lines of continuous glucose monitors, announced this week that it's ...

WASHINGTON, D.C. — The Food and Drug Administration (FDA) announced that Abbott has initiated ... component of the FreeStyle ...

Abbott recently launched a smartphone app that works with both its FreeStyle Libre 2 and FreeStyle Libre 3 CGM systems.

Linking the systems will allow clinicians to view glucose data captured by Libre glucose sensors within Epic’s systems.

Abbott has launched the new Libre app in the U.S., making it easier than ever for users of both the FreeStyle Libre 2 and FreeStyle Libre 3 systems to track glucose readings and insights.

Abbott has entered a first-of-its-kind agreement to integrate data from FreeStyle Libre CGM systems directly into Epic electronic health record systems in the United States, allowing clinicians to vie ...

Abbott's wearable FreeStyle Libre 3 device – which is billed as the smallest and thinnest real-time CGM system available – sends glucose readings every minute directly to the user's smartphone ...

Medtronic announced today that it submitted 510(k) applications to the FDA seeking clearance for an interoperable insulin ...

Continuous glucose meters (CGMs) aren’t just widgets for the wellness crowd. For many, CGMs are real-time feedback machines ...

ABBOTT PARK, Ill ... Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 3 and 2 systems, as feature sets are similar ...